Xiangqi Li
- Topics
- Hippo pathway signaling and YAP/TAZ (5 papers)Wnt/β-catenin signaling in development and cancer (5 papers)Ubiquitin and proteasome pathways (3 papers)
- Cited by
- Cell BiologyOncologyCancer Research
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Xiangqi Li
31 papers receiving 404 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 217
- Oncology 116
- Cell Biology 112
- Cancer Research 62
- Immunology 51
Countries citing papers authored by Xiangqi Li
This map shows the geographic impact of Xiangqi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangqi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangqi Li more than expected).
Fields of papers citing papers by Xiangqi Li
This network shows the impact of papers produced by Xiangqi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangqi Li. The network helps show where Xiangqi Li may publish in the future.
Co-authorship network of co-authors of Xiangqi Li
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangqi Li. A scholar is included among the top collaborators of Xiangqi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangqi Li. Xiangqi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 6 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | 33 | |
| 11 | 7 | |
| 12 | 21 | |
| 13 | 5 | |
| 14 | 12 | |
| 15 | 21 | |
| 16 | 67 | |
| 17 | 10 | |
| 18 | 15 | |
| 19 | 63 | |
| 20 | Effects of Shugan jianpi formula on lymphangiogenesis and expressions of Ang-2 and nm23 in breast cancer tissue | 1 |
About Xiangqi Li
Xiangqi Li is a scholar working on Cell Biology, Immunology and Oncology, having authored 33 papers that have together received 405 indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Cell Biology (112 citations), Oncology (116 citations) and Cancer Research (62 citations). Xiangqi Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Changran Wei, Ying Wang, Guodong Li, Liyan Sun, Kai Li, Wenjing Li, Jimei Zhang, Huiwen Hu, Keqiang Wang and Zhe‐Sheng Chen. Their work appears in journals such as Frontiers in Immunology, Frontiers in Pharmacology and Energies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.